Oncuria
Ten-protein urine multiplex immunoassay for bladder-cancer diagnostic, recurrence-monitoring and response-prediction contexts.
- Developer
- DiaCarta
- Intended use
- Diagnostic Aid, Recurrence Detection, Risk Stratification
- Cancer scope
- Bladder cancer
- Specimen
- Urine
- Molecular modality
- Protein
- Current version
- Current Oncuria Multiplex Immunoassay for Bladder Cancer, catalog DC-03-1001; 10 urine protein biomarkers
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.